Evidence map›Paper›PMID 40137232›Full record

ArticleJournal of fungi (Basel, Switzerland)2025

Gut Mycobiome Changes During COVID-19 Disease.

Danil V Krivonos, Dmitry E Fedorov, Ksenia M Klimina, Vladimir A Veselovsky, Svetlana N Kovalchuk, Alexander V Pavlenko, Oleg O Yanushevich, Dmitry N Andreev, Filipp S Sokolov, Aleksey K Fomenko and 11 more

Abstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Danil V KrivonosResearch Institute for Systems Biology and Medicine (RISBM), 18, Nauchniy Proezd, 117246 Moscow, Russia.ORCID 0000-0002-3851-5873
Dmitry E FedorovResearch Institute for Systems Biology and Medicine (RISBM), 18, Nauchniy Proezd, 117246 Moscow, Russia.
Ksenia M KliminaLopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, ul. Malaya Pirogovskaya, 1s3, 119435 Moscow, Russia.
Vladimir A VeselovskyLopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, ul. Malaya Pirogovskaya, 1s3, 119435 Moscow, Russia.ORCID 0000-0002-4336-9452
Svetlana N KovalchukResearch Institute for Systems Biology and Medicine (RISBM), 18, Nauchniy Proezd, 117246 Moscow, Russia.
Alexander V PavlenkoResearch Institute for Systems Biology and Medicine (RISBM), 18, Nauchniy Proezd, 117246 Moscow, Russia.
Oleg O YanushevichFederal State Budgetary Educational Institution of Higher Education "Russian University of Medicine" of the Ministry of Health of the Russian Federation, 127006 Moscow, Russia.
Dmitry N AndreevFederal State Budgetary Educational Institution of Higher Education "Russian University of Medicine" of the Ministry of Health of the Russian Federation, 127006 Moscow, Russia.ORCID 0000-0002-4007-7112
Filipp S SokolovFederal State Budgetary Educational Institution of Higher Education "Russian University of Medicine" of the Ministry of Health of the Russian Federation, 127006 Moscow, Russia.ORCID 0000-0003-2813-6498
Aleksey K FomenkoFederal State Budgetary Educational Institution of Higher Education "Russian University of Medicine" of the Ministry of Health of the Russian Federation, 127006 Moscow, Russia.ORCID 0000-0002-1794-7263
Mikhail K DevkotaFederal State Budgetary Educational Institution of Higher Education "Russian University of Medicine" of the Ministry of Health of the Russian Federation, 127006 Moscow, Russia.
Nikolai G AndreevFederal State Budgetary Educational Institution of Higher Education "Russian University of Medicine" of the Ministry of Health of the Russian Federation, 127006 Moscow, Russia.
Andrey V ZaborovskyFederal State Budgetary Educational Institution of Higher Education "Russian University of Medicine" of the Ministry of Health of the Russian Federation, 127006 Moscow, Russia.
Sergei V TsaregorodtsevFederal State Budgetary Educational Institution of Higher Education "Russian University of Medicine" of the Ministry of Health of the Russian Federation, 127006 Moscow, Russia.ORCID 0000-0002-0254-0516
Vladimir V EvdokimovFederal State Budgetary Educational Institution of Higher Education "Russian University of Medicine" of the Ministry of Health of the Russian Federation, 127006 Moscow, Russia.ORCID 0000-0001-9281-579X
Natella I KrikheliFederal State Budgetary Educational Institution of Higher Education "Russian University of Medicine" of the Ministry of Health of the Russian Federation, 127006 Moscow, Russia.
Petr A BelyFederal State Budgetary Educational Institution of Higher Education "Russian University of Medicine" of the Ministry of Health of the Russian Federation, 127006 Moscow, Russia.
Oleg V LevchenkoFederal State Budgetary Educational Institution of Higher Education "Russian University of Medicine" of the Ministry of Health of the Russian Federation, 127006 Moscow, Russia.
Igor V MaevFederal State Budgetary Educational Institution of Higher Education "Russian University of Medicine" of the Ministry of Health of the Russian Federation, 127006 Moscow, Russia.
Vadim M GovorunResearch Institute for Systems Biology and Medicine (RISBM), 18, Nauchniy Proezd, 117246 Moscow, Russia.ORCID 0000-0003-0837-8764
Elena N IlinaResearch Institute for Systems Biology and Medicine (RISBM), 18, Nauchniy Proezd, 117246 Moscow, Russia.ORCID 0000-0003-0130-5079

Funding

The government task №056-00108-22-01The government task № 122030900064-9
6 · The paper itself

Abstract

The majority of metagenomic studies are based on the study of bacterial biota. At the same time, the COVID-19 pandemic has prompted interest in the study of both individual fungal pathogens and fungal communities (i.e., the mycobiome) as a whole. Here, in this work, we investigated the human gut mycobiome during COVID-19. Stool samples were collected from patients at two time points: at the time of admission to the hospital (the first time point) and at the time of discharge from the hospital (the second time point). The results of this study revealed that

Indexed as

COVID-19fungal communitygut microbiome

Identifiers

PMID40137232
PMCPMC11943151

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.